Welcome to cider

Field	Query

Alzheimer disease
Amyotrophic lateral sclerosis
Autism
Bipolar disorder
COXPD
Cancer
Cardiovascular diseases
Diabetes mellitus, type II
Epilepsy
Farber lipogranulomatosis
Inflammatory bowel disease
Lung disease
Major depressive disorder
Multiple sclerosis
Muscular atrophy
Neutropenia, severe congenital
Other
Parkinson disease
Post-traumatic stress disorder
Postpartum depression
Rare disease
Schizophrenia

	Field	Term

General Information:

Id:	6,731 (click here to show other Interactions for entry)
Diseases:	Cancer Lung cancer - [OMIM]
Organism:	Homo sapiens
Publication type:	article
Reference:	Wu YY et al.(2011) SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer Oncogene 30: 3682-3693 [PMID: 21441952]

Interaction Information:

Comment	The CUB domain of SCUBE3 interacted with the with the extracellular region of TGFbetaR-II indicating that SCUBE3 is a ligand of TGFbetaR-II and is therefore involved in TGF-beta signaling.
Formal Description Interaction-ID: 65173	gene/protein TGFBR2 increases_activity of process transforming growth factor beta receptor signaling pathway
Drugbank entries	Show/Hide entries for TGFBR2
Drugbank DB04077	Glycerol not specified TGFBR2
Drugbank DB04077	Glycerol not specified TGFBR2

Home
Contact

The Helmholtz Zentrum München Imprint and Privacy Policy apply.

© 2013 - Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH) Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany

Disclaimer: IBIS Databases and associated information are protected by copyright. This server and its associated data and services are for academic, non-commercial use only. The Helmholtz Zentrum München has no liability for the use of results, data or information which have been provided through this server. Neither the use for commercial purposes, nor the redistribution of IBIS database files to third parties nor the distribution of parts of files or derivative products to any third parties is permitted. Commercial users shall contact the Helmholtz Zentrum München for a separate users license.